Samsara BioCapital GP, LLC - Mar 13, 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
10%+ Owner
Signature
Samsara BioCapital GP, LLC, By /s/ Srinivas Akkaraju, Managing Member
Stock symbol
MLYS
Transactions as of
Mar 13, 2025
Transactions value $
$8,100,000
Form type
4
Date filed
3/17/2025, 09:05 PM
Previous filing
Nov 27, 2024
Next filing
Mar 25, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Purchase $8.1M +600K +11.82% $13.50 5.67M Mar 13, 2025 By Samsara BioCapital, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Samsara BioCapital GP, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Securities are directly held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Samsara LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.